The Newshound

Merck and Moderna's mRNA cancer vaccine cuts the risk of melanoma returning or killing patients by 42%

Drug giants Merck and Moderna's novel mRNA vaccine helps stop melanoma tumours coming back in patients. The jab slashed the combined risk of death or recurrence by 42%.

The results came from Merck and Moderna's own report on the mRNA vaccine.

MoreThe IndependentA novel mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returningThe IndependentmRNA cancer vaccine slashes melanoma death or recurrence risk by 42%NYTCancer Vaccine Cuts the Risk of Melanoma Recurrence, Merck and Moderna ReportReutersMerck/Moderna cancer vaccine cuts risk of death or recurrence from melanoma by over 40%
Read today's full feed at The Newshound →